Mesoblast (MSB) buys Osiris (OSIR) stem cell unit

The Australian stem cell biotech Mesoblast (MSB) has¬†reportedly reached a deal with the American stem cell biotech Osiris (OSIR) to buy Osiris’ mesenchymal stem cell (MSC) unit. This is a big development in the MSC field. Osiris and Mesoblast are two major players in this particular subfield of the stem cell world so this deal, …

Mesoblast (MSB) buys Osiris (OSIR) stem cell unit Read More »